Body mass index and breast cancer treatment-related lymphedema
- 16 January 2011
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 19 (6) , 853-857
Abstract
Purpose The main purpose was to examine longitudinally the influence of body mass index (BMI) and obesity on the development of breast cancer treatment-related lymphedema. We asked, does elevated BMI increase lymphedema risk? Methods A secondary analysis was conducted on de-identified data collected from 138 newly diagnosed breast cancer survivors who had arm-volume measurements and symptom assessment at pre-treatment baseline and measurements up to 30 months post-surgery in a prospective longitudinal parent study. Arm volume and weight data, part of the information collected during each participant visit, were examined. Results Breast cancer survivors whose BMI was ≥30 at the time of breast cancer treatment were approximately 3.6 times more likely to develop lymphedema at 6 months or greater after diagnosis than those with a BMI < 30 at the time of cancer treatment (95% confidence interval, C.I., for odds ratio, O.R., 1.42–9.04; p = 0.007). Those with a general BMI increase or a BMI rise to 30 or greater during their first 30 months of survivorship were not more likely to develop late-onset lymphedema than those who did not have similar changes in BMI. Conclusions Pre-treatment BMI may be a risk factor for lymphedema. Weight gain post-treatment may not be. Further research is warranted.Keywords
This publication has 26 references indexed in Scilit:
- Obesity is a Risk Factor for Developing Postoperative Lymphedema in Breast Cancer PatientsThe Breast Journal, 2010
- Predictors of Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection in Hong KongNursing Research, 2008
- Preoperative assessment enables the early diagnosis and successful treatment of lymphedemaCancer, 2008
- Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White womenBreast Cancer Research and Treatment, 2008
- Morbidity in Breast Cancer Patients with Sentinel Node Metastases Undergoing Delayed Axillary Lymph Node Dissection (ALND) Compared with Immediate ALNDAnnals of Surgical Oncology, 2007
- Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedemaSupportive Care in Cancer, 2005
- Influence of some anthropometric parameters on the risk of development of distal complications after mastectomy carried out because of breast carcinomaAmerican Journal of Human Biology, 2003
- Breast Cancer Lymphedema: Pathophysiology and Risk Reduction GuidelinesOncology Nursing Forum, 2002
- Comparison of microvascular filtration in human arms with and without postmastectomy oedemaExperimental Physiology, 1999
- Comparison of Microvascular Filtration in Human Arms with and without Postmastectomy OedemaExperimental Physiology, 1999